Table I.
Clinical Characteristics of the Patients Undergoing Device Extraction for Elective Generator Replacement or Pocket Infections
| Elective Generator Replacement (N = 66) |
Pocket Infection (N = 16) |
P Value | |
|---|---|---|---|
| Age (years) | 70.8 ± 18.1 | 67.2 ± 17.4 | 0.47 |
| Gender | |||
| Female | 21 (31.8%) | 7 (43.8%) | 0.81 |
| Male | 45 (68.2%) | 9 (56.3%) | 0.43 |
| Device explanted | |||
| Pacemaker | 34 (51.5%) | 12 (75%) | 0.86 |
| ICD | 32 (49.5%) | 4 (25%) | 0.20 |
| Duration of implant (years) | 5.7 ± 6.0 | 3.2 ± 4.9 | 0.036 |
| Previous generator changes | 12 (18.2%) | 7 (43.8%) | 0.97 |
| Comorbidities | |||
| Diabetes mellitus | 16 (24.2%) | 5 (31.2%) | 0.77 |
| Hypertension | 51 (77.3%) | 9 (56.3%) | 0.32 |
| Hyperlipidemia | 35 (53.0%) | 7 (43.8%) | 0.45 |
| Chronic renal insufficiency (Stage 4/5) | 9 (13.6%) | 2 (12.5%) | 0.64 |
| Coronary artery disease | 35 (53.0%) | 7 (43.8%) | 0.45 |
| Congestive heart failure | 43 (65.2%) | 9 (56.3%) | 0.47 |
| Medications | |||
| Angiotensin-converting enzyme inhibitor | 30 (45.5%) | 6 (37.5%) | 0.46 |
| Angiotensin receptor blocker | 12 (18.2%) | 2 (12.5%) | 0.48 |
| β-blocker | 46 (69.7%) | 13 (81.3%) | 0.72 |
| Aspirin | 40 (60.6%) | 10 (62.5%) | 0.62 |
| Plavix | 3 (4.5%) | 2 (12.5%) | 0.94 |
| Coumadin | 27 (40.9%) | 5 (31.2%) | 0.43 |
| Amiodarone | 11 (16.7%) | 2 (12.5%) | 0.54 |
| Chronic oral steroids | 1 (1.5%) | 0 (0%) | 0.81 |